The harborview medical center medication assisted treatment-prescription drug and opioid addiction (short title: mat pdoa)
Ended Project Grant Awarded Last action
- Award ID
- H79TI084347
- Recipient
-
Harborview Medical Center UEI RSMSNTV2Z425 Part of University Of Washington
- Awarding agency
-
SAMHSA Division of Grants Management
Substance Abuse and Mental Health Services Administration, Department of Health and Human Services
- Obligated
- $7,161,000
Award facts
- Assistance listing
- 93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance
- Completion date
- Funding
-
- $6,111,000.00 Federal
- $1,050,000.00 Non-federal
- Funding agency
- SAMHSA Center for Substance Abuse Treatment Substance Abuse and Mental Health Services Administration, Department of Health and Human Services
- Place of performance
- Seattle, WA 98104, USA
Award details come from USAspending.gov.
Description
- Abstract
- Summary project name: the harborview medical center medication assisted treatment-prescription drug and opioid addiction project (HMC mat-pdoa) project summary: the HMC mat-pdoa will expand access to integrated medication assisted treatment (mat) for individuals with opioid use disorder (OUD). Building on our successful experience with a proven model of providing mat in an urban safety net medical setting, we will expand capacity to treat more patients and enhance services for patients with OUD presenting for care in the HMC emergency department (ED) and HMC inpatient services. HMC-mat-pdoa is a collaborative effort between harborview medical center and washington state to address the rising rates of opioid-related problems in washington state, including overdose deaths and addiction treatment admissions. The populations to be served are adults with OUD in king county, washington who are initiated onto mat during an inpatient hospital or ED admission. Strategies and interventions include three evidence-based practices (EBPS): 1) mat with buprenorphine/naloxone, extended-release naltrexone, or injectable buprenorphine, 2) the massachusetts nurse care manager model for providing mat in medical settings, and 3) peer support services. To address the specific needs of the target population, peer navigation services and inpatient addiction medicine physician consultations will be used to assess hospitalized patients for mat, choose the appropriate medication, initiate mat, and connect patients with transitional and primary care. Project goals are to: 1) increase mat capacity using a proven model for providing integrated services in medical settings; 2) develop enhanced services for hospitalized and ED patients with OUD and high rates of stimulant (primarily methamphetamine) use and homelessness; and 3) advance data 2000 training for eligible medical providers serving marginalized patients in medical settings. Objectives include, but are not limited to: 1) serve 900 unduplicated patients over a five-year period (180 patients in each year), 2) assure access to comprehensive services in a culturally competent, patient-centered care manner, 3) reduce adverse OUD-related outcomes and substance use from baseline to 6-month follow-up, 4) maximize retention in mat, 5) reduce disparities in mat access, 6) increase the number of high-cost hospitalized patients who are engaged in mat through inpatient physician consultations, 7) increase the use of peer navigation support for high need patients, 8) reduce the likelihood of medication diversion, 8) increase access to HIV/HCV screening and treatment, and tobacco cessation services, 9) increase referrals from local jails/prisons, 10) seek sustainable program financing, and 11) train clinical staff in the use of EBPS, including data waiver training. This project will be done in collaboration with the washington state research and data analysis, which will provide technical support, ongoing evaluation, and policy support.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $462,000 | $0 | |
| Amendment | $462,000 | $0 | |
| Amendment | $462,000 | $0 | |
| Amendment | $525,000 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $525,000 | $0 | |
| Amendment | $525,000 | $0 | |
| Amendment | $525,000 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $525,000 | $0 | |
| Amendment | $525,000 | $525,000 | |
| Amendment | $525,000 | $0 | |
| Amendment | $525,000 | $0 | |
| Original award | $525,000 | $525,000 |
Show all 22
Quick answers
Who received award H79TI084347?
H79TI084347 was awarded to Harborview Medical Center by SAMHSA Division of Grants Management (Substance Abuse and Mental Health Services Administration) on September 30, 2021.
How much is award H79TI084347 worth?
$7,161,000 has been obligated on H79TI084347: $6,111,000 in federal funding and $1,050,000 in non-federal funding.
Which agency awarded H79TI084347?
SAMHSA Division of Grants Management (Substance Abuse and Mental Health Services Administration) awarded H79TI084347, with funding from SAMHSA Center for Substance Abuse Treatment (Substance Abuse and Mental Health Services Administration).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award